Preoperative Physical Activity Before Radical Cystectomy and the Impact on Morbidity

Recruiting N/A Interventional Study
Urothelial Carcinoma Bladder
No Placebo Group Every participant receives an active treatment — no one gets a placebo.
Ready to participate?

Review the details below, then apply to join this clinical trial.

At a Glance
Age
18 and older
Sex
Any
Study type
Interventional
Purpose
Prevention
Participants needed
146 (estimated)
Sponsor
Ludwig-Maximilians - University of Munich · Other
Think this trial could be right for you?

Answer a few quick questions to see if you may meet the eligibility requirements.

Check Your Eligibility
About This Trial
Bladder cancer (BC) is the 6th most common tumor in Europe, with over 540,000 new cases globally each year. While 75% of cases are non-muscle-invasive and treated bladder-preservingly, muscle-invasive, non-metastatic BC requires radical cystectomy (RC), often with neoadjuvant chemotherapy. RC has one of the highest complication rates in urology, and rehabilitation focuses on mitigating functional …
Trial Locations
Loading…

Loading trial locations…

Eligibility Criteria
Inclusion Criteria: * Urothelial cell cancer of the bladder * Treatment with radical cystectomy Exclusion Criteria: * Need for walking aid * Depression * cardiovascular, neuromuscular or orthopaedic deficites / disorders * Time to surgery \< 3 Weeks
Contacts

Yannic Volz, PD Dr. med.

+49 089 4400 75970

yannic.volz@med.uni-muenchen.de

CONTACT